红细胞交换调节中性粒细胞脱粒反应在状细胞疾病中
Grace M Lee1, Kimberly Boyle1, Milena Batchvarova1
1Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Transfusion
|July 9, 2024
概括
在状细胞病 (SCD) 中,红细胞交换 (RCE) 疗法显著降低了中性粒细胞活化. 这种影响是持续的,并且与较低的血红蛋白S (HbS) 水平有关,可能改善治疗结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 中性粒细胞在状细胞疾病 (SCD) 中被激活,有助于疾病病理.
- 红细胞交换 (RCE) 是一种针对SCD的疗法,旨在降低血红蛋白S (HbS).
- RCE对SCD中中性粒细胞活性的影响尚不清楚.
研究的目的:
- 为了研究RCE对SCD患者中性粒细胞激活的影响.
- 确定RCE对中性粒细胞功能影响的持续时间和影响因素.
- 探索红细胞酸素 (RBC PS) 暴露在RCE对中性粒细胞活性调节中的作用.
主要方法:
- 接受RCE的SCD患者被纳入,在手术前后评估中性粒细胞脱粒反应.
- 动力学研究评估了RCE对中性粒细胞功能影响的持续时间.
- 检查了脱粒化,白细胞计数,中性粒细胞计数,HbS水平和红细胞PS暴露之间的相关性.
主要成果:
- 在SCD患者中,RCE显著降低了中性粒细胞脱粒反应.
- 中性粒细胞激活的减少与减少的HbS水平直接相关,而不是细胞计数.
- RCE在几天内维持了中性粒细胞激活的减少,并降低了红细胞PS暴露.
结论:
- 在SCD患者中,RCE治疗显然以持续的,依赖于HbS的方式降低了中性粒细胞激活.
- RCE对RBCPS暴露的调节可能是减少中性粒细胞激活的关键机制.
- 这些发现表明,缓解中性粒细胞激活是RCE在SCD治疗益处的重要贡献者.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K